Yue P - Search Results

1

Expression of Death Receptor 4 Is Positively Regulated by MEK/ERK/AP-1 Signaling and Suppressed upon MEK Inhibition.

Yao W, Oh YT, Deng J, Yue P, Deng L, Huang H, Zhou W, Sun SY. Yao W, et al. Among authors: yue p. J Biol Chem. 2016 Oct 7;291(41):21694-21702. doi: 10.1074/jbc.M116.738302. Epub 2016 Aug 30. J Biol Chem. 2016. PMID: 27576686 Free PMC article.

2

p53 upregulates death receptor 4 expression through an intronic p53 binding site.

Liu X, Yue P, Khuri FR, Sun SY. Liu X, et al. Among authors: yue p. Cancer Res. 2004 Aug 1;64(15):5078-83. doi: 10.1158/0008-5472.CAN-04-1195. Cancer Res. 2004. PMID: 15289308

3

The farnesyltransferase inhibitor lonafarnib induces CCAAT/enhancer-binding protein homologous protein-dependent expression of death receptor 5, leading to induction of apoptosis in human cancer cells.

Sun SY, Liu X, Zou W, Yue P, Marcus AI, Khuri FR. Sun SY, et al. Among authors: yue p. J Biol Chem. 2007 Jun 29;282(26):18800-9. doi: 10.1074/jbc.M611438200. Epub 2007 May 9. J Biol Chem. 2007. PMID: 17493934 Free article.

4

Proteasome inhibitor PS-341 (bortezomib) induces calpain-dependent IkappaB(alpha) degradation.

Li C, Chen S, Yue P, Deng X, Lonial S, Khuri FR, Sun SY. Li C, et al. Among authors: yue p. J Biol Chem. 2010 May 21;285(21):16096-104. doi: 10.1074/jbc.M109.072694. Epub 2010 Mar 24. J Biol Chem. 2010. PMID: 20335171 Free PMC article.

5

ERK/ribosomal S6 kinase (RSK) signaling positively regulates death receptor 5 expression through co-activation of CHOP and Elk1.

Oh YT, Liu X, Yue P, Kang S, Chen J, Taunton J, Khuri FR, Sun SY. Oh YT, et al. Among authors: yue p. J Biol Chem. 2010 Dec 31;285(53):41310-9. doi: 10.1074/jbc.M110.153775. Epub 2010 Nov 2. J Biol Chem. 2010. PMID: 21044953 Free PMC article.

6

Oncogenic Ras and B-Raf proteins positively regulate death receptor 5 expression through co-activation of ERK and JNK signaling.

Oh YT, Yue P, Zhou W, Balko JM, Black EP, Owonikoko TK, Khuri FR, Sun SY. Oh YT, et al. Among authors: yue p. J Biol Chem. 2012 Jan 2;287(1):257-267. doi: 10.1074/jbc.M111.304006. Epub 2011 Nov 7. J Biol Chem. 2012. PMID: 22065586 Free PMC article.

7

Protein phosphatase 2A and DNA-dependent protein kinase are involved in mediating rapamycin-induced Akt phosphorylation.

Li Y, Wang X, Yue P, Tao H, Ramalingam SS, Owonikoko TK, Deng X, Wang Y, Fu H, Khuri FR, Sun SY. Li Y, et al. Among authors: yue p. J Biol Chem. 2013 May 10;288(19):13215-24. doi: 10.1074/jbc.M113.463679. Epub 2013 Mar 27. J Biol Chem. 2013. PMID: 23536185 Free PMC article.

8

Enhancing therapeutic efficacy of the MEK inhibitor, MEK162, by blocking autophagy or inhibiting PI3K/Akt signaling in human lung cancer cells.

Yao W, Yue P, Zhang G, Owonikoko TK, Khuri FR, Sun SY. Yao W, et al. Among authors: yue p. Cancer Lett. 2015 Aug 1;364(1):70-8. doi: 10.1016/j.canlet.2015.04.028. Epub 2015 Apr 29. Cancer Lett. 2015. PMID: 25937299 Free PMC article.

9

The novel proteasome inhibitor carfilzomib activates and enhances extrinsic apoptosis involving stabilization of death receptor 5.

Han B, Yao W, Oh YT, Tong JS, Li S, Deng J, Yue P, Khuri FR, Sun SY. Han B, et al. Among authors: yue p. Oncotarget. 2015 Jul 10;6(19):17532-42. doi: 10.18632/oncotarget.3947. Oncotarget. 2015. PMID: 26009898 Free PMC article.

10

The BET bromodomain inhibitor, JQ1, facilitates c-FLIP degradation and enhances TRAIL-induced apoptosis independent of BRD4 and c-Myc inhibition.

Yao W, Yue P, Khuri FR, Sun SY. Yao W, et al. Among authors: yue p. Oncotarget. 2015 Oct 27;6(33):34669-79. doi: 10.18632/oncotarget.5785. Oncotarget. 2015. PMID: 26415225 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

909 results

Search Page

Filters